0000904454-21-000537.txt : 20210617 0000904454-21-000537.hdr.sgml : 20210617 20210617100901 ACCESSION NUMBER: 0000904454-21-000537 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALOZ PIERRE CENTRAL INDEX KEY: 0001867944 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36294 FILM NUMBER: 211023606 MAIL ADDRESS: STREET 1: UNIQURE N.V. STREET 2: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: P7 11058BP ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP BUSINESS PHONE: 1-339-970-7000 MAIL ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-06-15 0001590560 uniQure N.V. QURE 0001867944 CALOZ PIERRE C/O UNIQURE N.V. PAASHEUVELWEG 25A AMSTERDAM P7 11058BP NETHERLANDS 0 1 0 0 Chief Operating Officer Ordinary Shares 2021-06-15 4 A 0 10000.0 0.0 A 10000.0 D Ordinary Shares 2021-06-15 4 A 0 25000 0 A 35000 D Stock option (Right to Buy) 34.46 2021-06-15 4 A 0 75000 0 A 2031-06-15 Ordinary Shares 75000 75000 D Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in full on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest pro-rata on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through each such date. The Stock Option vests over four years, with 25% vesting on the first anniversary of the date of grant and then quarterly on a pro-rata basis during the remainder of the vesting period, subject to the Reporting Person's continued relationship with the Issuer through each such date. /s/ Christian Klemt, Attorney-in-Fact 2021-06-17